EdgeTestMarket TodayOptions TodayIPO
Start free

TECILCHEMTECIL Chemicals and Hydro Power Limited

Rs 8.31▼ -3.15%
Market closedEquity EOD 27 Oct
Compare
52-week rangeThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.2.2% up the range
Rs 8Rs 22
TECILCHEM price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 27 Oct
IndicatorsVolume

Loading TECILCHEM price...

At a glance
Each figure is shown against the company's sector (the track: the dot is this company, the tick is the sector middle) and, where we hold the yearly filings, against its own recent years (the small trend line).
Market capWhat the whole company is worth on the stock market today: share price times the number of shares. It measures size, not quality.
Rs 16 cr
Larger than 0% of 19 peers
sector middle Rs 1,038 cr
ROEReturn on equity: the year's profit as a percentage of the shareholders' money in the business. It shows how much the company earns on what its owners have put in.
2.3%
Full year FY26
FY23 8.0%FY26 2.3%
ROCEReturn on capital employed: operating profit as a percentage of all the long-term money in the business, owners' and lenders'. It shows how well the company uses its capital, whatever the mix of debt.
7.4%
Around the middle of 19 peers
sector middle 10.4%
FY23 31.0%FY26 7.4%
Dividend yieldDividends paid over the last year as a percentage of the company's market value: roughly what Rs 100 of shares paid out in cash.
0.0%
Lower than 74% of 19 peers
sector middle 0.4%

Peers are the listed companies in the exchange's own industry group: Commodity Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to June 2026 (results filed 12 Aug 2026), sales was Rs 0.0 cr and the loss was Rs 0.2 cr against Rs 0.1 cr a year earlier.

Worth watching
  • Reported a loss in FY24 and FY25 and FY26.
  • Return on equity stayed under 10% from FY24 to FY26 (highest 2.3%).

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

How the share moved on results
For each quarterly result we hold: the change from the share's close on the last trading day before the filing to its close on the first trading day after it. Results can land during market hours or after the close, and this window covers both. It shows what happened, not what will happen next time.

Over the last 13 results, the share rose on 4 and fell on 9, and moved by 3% or more on 7.

Q4 FY23Q4 FY24Q1 FY26Q1 FY27

Q1 FY27: results filed 12 Aug 2026. The share went from its close on 11 Aug 2026 to its close on 13 Aug 2026 -0.12%.

Fundamentals
Trailing-twelve-month valuation, margins and growth from the company's own filings.

We do not have quarterly financials for TECILCHEM yet. Some companies, mainly insurers, file in a format we cannot read at the moment. Everything else on this page is current.

Health check, year by year
Returns and debt for each financial year from the March balance sheet, each row coloured against this company's own usual level.
MeasureFY23FY24FY25FY26
ROEProfit as a percentage of shareholders' money (from the March balance sheet).8.0%2.3%2.1%2.3%
ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'.31.0%9.0%6.8%7.4%

Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).

What it owns, and how that is paid for
Straight from the March balance sheet in the company's annual filing. Both bars are the whole balance sheet: what the company owns, and where the money for it came from.
as at 2026-03-31

At FY26 it owned Rs 4 Cr of assets. Its owners funded 0% of that and borrowings 299%.

What it owns
78%
21%
Plant, property and projects3 Cr
Investments0 Cr
Cash and bank0 Cr
Everything else1 Cr
How that is paid for
299%
233%
Borrowings13 Cr
Owed to suppliers0 Cr
Other liabilities10 Cr
Cash and equivalents
Rs 0 Cr
Net debt
Rs 13 Cr
Current ratio
0.09x
short-term assets per rupee due soon

From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.

Where the cash went
Profit is an accounting figure; cash flow is what actually moved. Cash from running the business, plus or minus what was spent on or received from investments, plus or minus what came from or went to lenders and shareholders, equals the change in cash.

In FY26 the business itself brought in Rs -0 Cr, and cash rose by Rs 0 Cr over the year.

From running the business
-0 Cr
Spent on or received from investing
+0 Cr
From or to lenders and shareholders
+0 Cr
Net change in cash
+0 Cr

Full financial year to 2026-03-31, from the company's cash flow statement.

The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
5 years · 20 quarters
Full financial years - the long arc of the business.
Sales growth
-
a year, 3 years
Profit growth
-
a year, 3 years
Operating margin
-
latest year
Sales by financial yearRs 0 Cr
Net profit by financial yearRs -0 Cr
FY225 full years · hover a yearFY26

Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.

Large institutional deals
Bulk and block deals reported by the exchange, where a single large trade is disclosed along with the counterparty's name. Only deals above the exchange's disclosure threshold appear here.
last 2
DatePartySideQtyPriceValue
2026-09-25ICICI BANK LIMITEDSELL1,08,0008.97Rs 0.1 Cr
2026-08-04CANARA BANKSELL1,08,38210.23Rs 0.11 Cr
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 27 Oct
RSI (14) - momentum
35.9Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
93.4%Near average
today 93.4%20d avg 79.9%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50-DMA
-10.80%
vs 200-DMA
-29.13%
1-month
-10.16%
3-month
-16.82%
1-year
-52.97%
Realized vol (30d)
51.3%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on TECILCHEM?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.